Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-05-10 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2018年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the 2018 Annual General Meeting (AGM) resolutions of Huabang Life Health Co., Ltd. It details the voting results on various proposals including the 2018 Board Work Report, Supervisory Board Work Report, Financial Statements, Profit Distribution Plan, Annual Report and its summary, Special Report on Fund Usage, and the reappointment of the audit firm. It also includes information about the meeting attendance, legal opinions, and independent directors' reports. The document primarily reports the official voting results and resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is 2766 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-10 Chinese
2018年年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2018 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It details the convening, attendance, voting procedures, and results of the AGM. The document focuses on the legality and validity of the AGM process and voting outcomes, rather than presenting financial statements or company performance data. It is not the actual Annual Report or financial report but a legal opinion related to the AGM. Therefore, it fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including legal opinions on the meeting.
2019-05-10 Chinese
向特定对象发行股份购买资产并募集配套资金暨关联交易的限售股份上市流通的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance of shares to specific parties for asset purchase and fundraising, including information about restricted shares, their unlocking dates, and related shareholder commitments. It includes tables of shareholding changes, lock-up periods, and compliance with lock-up commitments. The content focuses on share issuance, capital raising, and related transactions rather than financial results, management changes, or legal proceedings. It is not a full financial report, earnings release, or management discussion. The document is a formal announcement about capital raising and share issuance activities, fitting the Capital/Financing Update category.
2019-05-08 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of the company, indicating it is a quarterly financial report. It contains detailed financial data such as income, net profit, cash flow, assets, liabilities, shareholder information, and explanations of financial changes during the quarter. The length of the document (13,805 characters) and the presence of substantive financial statements and analysis confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-29 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled '2019年第一季度报告' which translates to '2019 First Quarter Report'. It contains detailed financial data including income, net profit, cash flow, assets, liabilities, shareholder information, and financial statements such as the consolidated balance sheet dated March 31, 2019. The content includes comprehensive financial metrics and analysis for a period shorter than a full fiscal year (quarterly). The length of the document (15,000 characters) and the presence of actual financial statements confirm it is a full quarterly report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-29 Chinese
关于股票期权激励计划已授予股票期权注销完成的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (620 characters) about the completion of the cancellation of granted stock options under a stock option incentive plan. It references prior announcements and legal opinions but does not contain financial statements or detailed financial data. The content is about a corporate action related to stock options, specifically the cancellation of granted but unexercised stock options. This fits best under the category of a Regulatory Filing (RNS) because it is a regulatory announcement about a corporate action and does not qualify as a full report or detailed financial disclosure. It is not a capital/financing update (CAP) because it does not discuss new financing or capital raising, but rather the cancellation of options. It is also not a share issue or capital change (SHA) because it does not announce new shares or capital changes but the cancellation of options. Therefore, the best classification is Regulatory Filings (RNS).
2019-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.